News
A ctDNA-guided approach can help identify when patients with HR-positive advanced breast cancer are developing an ESR1 ...
April 3 (Reuters) - British pharmaceutical giant GlaxoSmithKline (GSK.L), opens new tab and rival Pfizer (PFE.N), opens new tab have agreed to end a lawsuit that alleged Pfizer's respiratory ...
GlaxoSmithKline (GSK – Research Report) received a Hold rating and a $41.00 price target from Berenberg Bank analyst Kerry Holford today. Confident Investing Starts Here: Easily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback